Dr. Ted A. Gooley

powered by
COS Expertise®
Fred Hutchinson Cancer Research Center
Clinical Statistics
Clinical Research
MemberAppointed: 2005
University of Washington
School of Public Health and Community Medicine
Biostatistics
Affiliate ProfessorAppointed: 2006
Fred Hutchinson Cancer Research Center
Biostatistics
Public Health Sciences
Member (Joint Appointment)Appointed: 2005
Professional Headshot of Ted A. Gooley

Mailing Address

Fred Hutchinson Cancer Research Center
1100 Fairview Avenue N., D5-360
P.O. Box 19024
Seattle, Washington 98109-1024
United States

Contact Information

Phone: (206) 667-6533
Fax: (206) 667-6358
tgooley@fhcrc.org

Qualifications

Ph.D., University of Arizona, Applied Mathematics, 1990.
B.S., Washington State University, Mathematics, 1984.

Expertise and Research Interests

Clinical trials and methods of data analysis in stem cell transplantation.

The Clinical Research Division at the FHCRC performs more stem cell transplants than any other institution in the world. The first transplant in Seattle was done in 1969, and currently roughly 450 transplants are done yearly. These facts put the FHCRC in a unique position to conduct both small- and large-scale clinical trials designed to address some of the most important and interesting questions that face the transplantation community today. The large volume of data generated from past transplants also provides a rich database from which information can be used to generate hypotheses and to monitor progress made in the field.

In recent years, many dose-finding studies have been designed within the Clinical Division with the goal of determining whether of not an effective dose of a treatment can be found such that the dose appears both safe and efficacious. This is in contrast to the more standard Phase I setting where one may be concerned only with safety and not efficacy. One such example is selective depletion of T cells in the donor marrow, where it is desired to find a dose of T cells that is associated with acceptable rates of graft failure while at the same timebeing associated with acceptable rates of severe graft-versus-host disease.

With the advent of the National Marrow Donor Program, use of alternative donors is becoming more commonplace for patients who lack a suitable family-member donor. It has beenshown in certain diseases that the time from diagnosis to transplant is an important prognostic factor in predicting outcome after transplantation and that outcome is adversely affected by donors who fail to share certain HLA antigens with the patient. A decision often needs to be made by both patient and physician whether to get transplanted early with a less-than-optimal donor or to wait longer in the hope of finding a more suitable donor. We are currently in the process of dealing with these and related issues for patients with chronic myeloid leukemia who receive a transplant from an unrelated donor.

The prevention and treatment of fungal and viral infections continues to be a problem following stem cell transplantation due to the immunocompromised condition of the patient. We have completed several randomized, controlled trials in recent years, and others are currently underway. These trials have led to significant progress in the prevention and treatment of certain infections, and the resultsof past and current clinical trials continue to shape strategies used to deal with such complications.

Keywords

COS Keywords:

Biostatistics, Bone Marrow, Epidemiology, Public Health, Stem Cells.

Memberships

American Statistical Association
Society for American Baseball Research
Society for Clinical Trials

Honors and Awards

Phi Beta Kappa
Phi Kappa Phi

Previous Positions

2002-2006, Affiliate Associate Professor, University of Washington, School of Public Health and Community Medicine, Biostatistics
1999-2005, Associate Member, Fred Hutchinson Cancer Research Center, Clinical Research Division, Clinical Statistics
1999-2005, Associate Member (Joint Appointment), Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Biostatistics
1993-2002, Affiliate Assistant Professor, University of Washington, School of Public Health and Community Medicine, Biostatistics
1992-1999, Assistant Member, Fred Hutchinson Cancer Research Center, Clinical Statistics, Clinical Research Division
1992-1999, Assistant Member (Joint Appointment), Fred Hutchinson Cancer Research Center, Public Health Sciences Division
1991-1992, Post-Doctoral Fellow, University of Rochester, Statistics
1984-1986, Graduate Teaching Assistant, University of Arizona, Mathematics
1983-1984, Undergraduate Teaching Assistant, Washington State University, College of Sciences, Mathematics

Publications

  • Lin MT, Gooley T, Hansen JA, Tseng LH, Martin EG, Singleton K, Smith AG, Mickelson E, Petersdorf EW, Martin PJ, Absence of statistically significant correlation between disparity for the minor histocompatibility antigen-HA-1 and outcome after allogeneic hematopoietic cell transplantation., Blood, 98(10), 3172-3, Nov 2001 Abstract
  • Torok-Storb B, Bolles L, Iwata M, Doney K, Sale GE, Gooley TA, Storb R, Increased prevalence of CMV gB3 in marrow of patients with aplastic anemia., Blood, 98(3), 891-2, Aug 2001 Abstract
  • Li Z, Gooley T, Applebaum FR, Deeg HJ, Splenectomy and hemopoietic stem cell transplantation for myelofibrosis., Blood, 97(7), 2180-1, Apr 2001 Abstract
  • Carpenter PA, Pavlovic S, Tso JY, Press OW, Gooley T, Yu XZ, Anasetti C, Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells, Journal of Immunology, 165(11), 6205-13, 2000 Abstract
  • Park JR, Slattery J, Gooley T, Hawkins D, Lindsley K, Villablanca JG, Matthay KK, Sanders JE, Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumors, Medical and Pediatric Oncology, 35(6), 719-23, December 2000 Abstract
  • Mathioudakis G, Storb R, McSweeney PA, Torok-Storb B, Lansdorp PM, Brummendorf TH, Gass MJ, Bryant E, Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipients, Blood, 96(12), 3991-4, 2000 Abstract
  • Press OW, Eary JF, Gooley T, Gopal AK, Liu S, Rajendran JG, Maloney DG, Petersdorf S, Bush SA, Durac, A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas, Blood, 96(9), 2934-42, 2000 Abstract
  • Chauncey TR, Gooley TA, Lloid ME, Schubert MM, Lilleby K, Holmberg L, Bensinger WI, Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantation, American Journal of Clinical Oncology, 23(4), 406-11, August 2000 Abstract
  • Disis ML, Schiffman K, Gooley TA, McNeel DG, Rinn K, Knutson KL, Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunization, Clinical Cancer Research, 6(4), 1347-50, April 2000 Abstract
  • Gooley TA, Leisenring W, Crowley J, Storer BE, Why Kaplan-Meier fails and cumulative incidence succeeds when estimating failure probabilities in the presence of competing risks, Handbook of Statistics in Clinical Oncology, 513-523, 2000
  • Radich JP, Gooley T, Sanders JE, Anasetti C, Chauncey T, Appelbaum FR, Second allogeneic transplantation after failure of first autologous transplantation, Biology of Blood and Marrow Transplantation, 6(3), 272-9, 2000 Abstract
  • Souza JP, Boeckh M, Gooley TA, Flowers ME, Crawford SW, High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis, Clinical Infectious Diseases, 29(6), 1467-71, December 1999 Abstract
  • Gooley TA, Leisenring W, Crowley J, Storer BE, Estimation of failure probabilities in the presence of competing risks: new representations of old estimators, Statistics in Medicine, 18(6), 695-706, 1999 Abstract
  • Boeckh M, Bowden RA, Gooley T, Myerson D, Corey L, Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients., Blood, 93(5), 1781-2, Mar 1999 Abstract
  • Woolfrey AE, Gooley TA, Sievers EL, Milner LA, Andrews RG, Walters M, Hoffmeister P, Hansen JA, Anas, Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome, Blood, 92(10), 3546-56, 1998 Abstract
  • Petersdorf EW, Gooley TA, Anasetti C, Martin PJ, Smith AG, Mickelson EM, Woolfrey AE, Hansen JA, Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient, Blood, 92(10), 3515-20, 1998 Abstract
  • Martin PJ, Schoch G, Gooley T, Anasetti C, Deeg HJ, Nash R, Sanders J, Storb R, Appelbaum F, Methods for assessment of graft-versus-host disease., Blood, 92(9), 3479-81, Nov 1998 Abstract
  • Liu SY, Eary JF, Petersdorf SH, Martin PJ, Maloney DG, Appelbaum FR, Matthews DC, Bush SA, Durack LD, Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue, Journal of Clinical Oncology, 16(10), 3270-8, October 1998 Abstract
  • Boeckh M, Gooley TA, Bowden RA, Effect of high-dose acyclovir on survival in allogeneic marrow transplant recipients who received ganciclovir at engraftment or for cytomegalovirus pp65 antigenemia, Journal of Infectious Diseases, 178(4), 1153-7, October 1998 Abstract
  • Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA, Petersdorf EW, Radich J, Sander, Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia, New England Journal of Medicine, 338(14), 962-8, 1998 Abstract
  • Martin PJ, Gooley T, Anasetti C, Petersdorf EW, Hansen JA, HLAs and risk of acute graft-vs.-host disease after marrow transplantation from an HLA-identical sibling, Biology of Blood and Marrow Transplantation, 4(3), 128-33, 1998 Abstract
  • Nash RA, Gooley T, Davis C, Appelbaum FR, The problem of thrombocytopenia after hematopoietic stem cell transplantation, Stem Cells, 14 Suppl 1, 261-73, 1996 Abstract
  • Gooley TA, Martin PJ, Fisher LD, Pettinger M, Simulation as a design tool for phase I/II clinical trials: an example from bone marrow transplantation, Controlled Clinical Trials, 15(6), 450-62, December 1994 Abstract
  • Gooley TA, Barrett HH, Roney TJ, Smith WE (1991) Use of Prior Information in Coded-Aperture Imaging, Institute of Mathematical Statistics Lection Notes - Monograph Series: Spatial Statistics and Imaging, Seattle, Boeing Computer Services, 90-102 pages (bookchapter)
  • Aarsvold JN, Barrett HH, Gooley TA, Roney TJ, Rowe RK, Smith WE (1991) Preliminary results from simulations of tomographic imaging using multiple-pinhole coded apertures, Medical Images: Formation, Handling and Evaluation, 397-409 pages (bookchapter)
  • Barth M, Denny JL, Gooley TA (1990) Regularization in coded-aperture SPECT, Maximum Entropy and Bayesian Methods, Netherlands, Kluwer Academic Publishers, 399-412 pages (bookchapter)
  • Lupu M, McCune JS, Kuhr CS, Gooley T, Storb R, Pharmacokinetics of oral mycophenolate mofetil in dog: bioavailability studies and the impact of antibiotic therapy (letter to the editor), Biology of Blood and Marrow Transplantation, In Press
  • Kerbauy DMB, Gooley TA, Sale GE, Flowers MED, Doney KC, Georges GE, Greene JE, Linenberger M, Petersdorf E, Sandmaier BM, Scott BL, Sorror M, Stirewalt DL, Stewart FM, Witherspoon RP, Storb R, Appelbaum FR, Deeg HJ (2006) Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polychthemia vera and essential thrombocythemia, Biology of Blood and Marrow Transplantation, In Press
  • Radich JP, Gehly G, Gooley T, Bryant E, Clift RA, Collins S, Edmands S, Kirk J, Lee A, Kessler P, Et Al. (May 1995) Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients., Blood, 85 (9), 2632-8 Abstract
  • Boeckh M, Gooley T, Leisenring W, Myerson D, Corey L (1999) Does high-dose acyclovir add benefit in allogeneic marrow transplant recippients receiving prophylactic or preemptive ganciclovir? (Letter to the Editor), The Journal of Infectious Diseases, 180, 572-574
  • Yusuf U, Frangoul HA, Gooley TA, Woolfrey AE, Carpenter PA, Andrews RG, Deeg HJ, Appelbaum FR, Anasetti C, Storb R, Sanders JE (Apr 2004) Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience., Bone Marrow Transplantation, 33 (8), 805-14 Abstract
  • Gopal AK, Gooley TA, Golden JB, Maloney DG, Bensinger WI, Petersdorf SH, Appelbaum FR, Press OW (Mar 2001) Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older., Bone Marrow Transplantation, 27 (6), 593-9 Abstract
  • Petersdorf EW, Anasetti C, Martin PJ, Gooley T, Radich J, Malkki M, Woolfrey A, Smith A, Mickelson E, Hansen JA (Nov 2004) Limits of HLA mismatching in unrelated hematopoietic cell transplantation., Blood, 104 (9), 2976-80 Abstract
  • McDonald GB, Slattery JT, Bouvier ME, Ren S, Batchelder AL, Kalhorn TF, Schoch HG, Anasetti C, Gooley T (Mar 2003) Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation., Blood, 101 (5), 2043-8 Abstract
  • Nichols WG, Corey L, Gooley T, Drew WL, Miner R, Huang M, Davis C, Boeckh M (Feb 2001) Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes., Blood, 97 (4), 867-74 Abstract
  • Zang DY, Deeg HJ, Gooley T, Anderson JE, Anasetti C, Sanders J, Myerson D, Storb R, Appelbaum F (Jul 2000) Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation., British Journal of Haematology, 110 (1), 217-22 Abstract
  • Platzbecker U, Gooley T, Anasetti C, Appelbaum FR, Clurman B, Doney K, Chauncey T, Flowers ME, Myerson D, Radich JP, Storb R, Witherspoon RP, Deeg HJ (Jul 2002) Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation., Leukemia & Lymphoma, 43 (7), 1409-14 Abstract
  • Disis ML, Gooley TA, Rinn K, Davis D, Piepkorn M, Cheever MA, Knutson KL, Schiffman K (Jun 2002) Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines., Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 20 (11), 2624-32 Abstract
  • Gopal AK, Gooley TA, Maloney DG, Petersdorf SH, Eary JF, Rajendran JG, Bush SA, Durack LD, Golden J, Martin PJ, Matthews DC, Appelbaum FR, Bernstein ID, Press OW (Oct 2003) High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable coho, Blood, 102 (7), 2351-7 Abstract
  • Linenberger ML, Hong T, Flowers D, Sievers EL, Gooley TA, Bennett JM, Berger MS, Leopold LH, Appelbaum FR, Bernstein ID (Aug 2001) Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin., Blood, 98 (4), 988-94 Abstract
  • Akatsuka Y, Warren EH, Gooley TA, Brickner AG, Lin MT, Hansen JA, Martin PJ, Madtes DK, Engelhard VH, Takahashi T, Riddell SR (Nov 2003) Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identica, British Journal of Haematology, 123 (4), 671-5 Abstract
  • Gopal AK, Rajendran JG, Petersdorf SH, Maloney DG, Eary JF, Wood BL, Gooley TA, Bush SA, Durack LD, Martin PJ, Matthews DC, Appelbaum FR, Bernstein ID, Press OW (May 2002) High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma., Blood, 99 (9), 3158-62 Abstract
  • Feinstein LC, Sandmaier BM, Maloney DG, Maris MB, Gooley TA, Chauncey TR, Hegenbart U, McSweeney PA, Stuart MJ, Forman SJ, Agura EA, Pulsipher MA, Blume KG, Niederwieser DW, Storb RF (Apr 2003) Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 9 (4), 266-72 Abstract
  • Rossbach HC, Krizanac-Bengez L, Santos EB, Gooley TA, Sandmaier BM (Feb 1996) An antibody to CD44 enhances hematopoiesis in long-term marrow cultures., Experimental Hematology, 24 (2), 221-7 Abstract
  • Boeckh M, Gooley TA, Reusser P, Buckner CD, Bowden RA (Oct 1995) Failure of high-dose acyclovir to prevent cytomegalovirus disease after autologous marrow transplantation., The Journal of Infectious Diseases, 172 (4), 939-43 Abstract
  • Demirer T, Buckner CD, Gooley T, Appelbaum FR, Rowley S, Chauncey T, Lilleby K, Storb R, Bensinger WI (Jun 1996) Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma., Bone Marrow Transplantation, 17 (6), 937-41 Abstract
  • Bruno B, Gooley T, Sullivan KM, Davis C, Bensinger WI, Storb R, Nash RA (2001) Secondary failure of platelet recovery after hematopoietic stem cell transplantation., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 7 (3), 154-62 Abstract
  • Rowley SD, Loken M, Radich J, Kunkle LA, Mills BJ, Gooley T, Holmberg L, McSweeney P, Beach K, MacLeod B, Appelbaum F, Bensinger WI (Jun 1998) Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system., Bone Marrow Transplantation, 21 (12), 1253-62 Abstract
  • Georges GE, Storb R, Bruno B, Brodie SJ, Thompson JD, Taranova AG, Zaucha JM, Little MT, Zellmer E, Moore PF, Gooley T, Sale G, Kiem HP, Sandmaier BM, Lyons RM, Nash RA (Dec 2001) Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes., Blood, 98 (12), 3447-55 Abstract
  • Slavin MA, Gooley TA, Bowden RA (Oct 1994) Prediction of cytomegalovirus pneumonia after marrow transplantation from cellular characteristics and cytomegalovirus culture of bronchoalveolar lavage fluid., Transplantation, 58 (8), 915-9 Abstract
  • Wallen H, Gooley TA, Deeg HJ, Pagel JM, Press OW, Appelbaum FR, Storb R, Gopal AK (May 2005) Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older., Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 23 (15), 3439-46 Abstract
  • Lee JL, Gooley T, Bensinger W, Schiffman K, McDonald GB (1999) Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 5 (5), 306-15 Abstract
  • Lorenz E, Schwartz DA, Martin PJ, Gooley T, Lin MT, Chien JW, Hansen JA, Clark JG (2001) Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 7 (7), 384-7 Abstract
  • Bruno B, Gooley T, Hackman RC, Davis C, Corey L, Boeckh M (May 2003) Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 9 (5), 341-52 Abstract
  • Deeg HJ, Gooley TA, Flowers ME, Sale GE, Slattery JT, Anasetti C, Chauncey TR, Doney K, Georges GE, Kiem HP, Martin PJ, Petersdorf EW, Radich J, Sanders JE, Sandmaier BM, Warren EH, Witherspoon RP, Storb R, Appelbaum FR (Dec 2003) Allogeneic hematopoietic stem cell transplantation for myelofibrosis., Blood, 102 (12), 3912-8 Abstract
  • McCune JS, Gooley T, Gibbs JP, Sanders JE, Petersdorf EW, Appelbaum FR, Anasetti C, Risler L, Sultan D, Slattery JT (Aug 2002) Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation., Bone Marrow Transplantation, 30 (3), 167-73 Abstract
  • Weaver CH, Bensinger WI, Appelbaum FR, Lilleby K, Sandmaier B, Brunvand M, Rowley S, Petersdorf S, Rivkin S, Gooley T, Et Al. (Nov 1994) Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies., Bone Marrow Transplantation, 14 (5), 813-9 Abstract
  • Carnevale-Schianca F, Martin P, Sullivan K, Flowers M, Gooley T, Anasetti C, Deeg J, Furlong T, McSweeney P, Storb R, Nash RA (2000) Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 6 (6), 613-20 Abstract
  • Deeg HJ, Shulman HM, Anderson JE, Bryant EM, Gooley TA, Slattery JT, Anasetti C, Fefer A, Storb R, Appelbaum FR (Feb 2000) Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age., Blood, 95 (4), 1188-94 Abstract
  • Gopal AK, Rajendran JG, Petersdorf SH, Maloney DG, Eary JF, Wood BL, Gooley TA, Bush SA, Durack LD, Martin PJ, Matthews DC, Appelbaum FR, Bernstein ID, Press OW (May 2002) High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma., Blood, 99 (9), 3158-62 Abstract
  • Gopal AK, Rajendran JG, Petersdorf SH, Maloney DG, Eary JF, Wood BL, Gooley TA, Bush SA, Durack LD, Martin PJ, Matthews DC, Appelbaum FR, Bernstein ID, Press OW (May 2002) High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma., Blood, 99 (9), 3158-62 Abstract
  • Lenssen P, Bruemmer BA, Bowden RA, Gooley T, Aker SN, Mattson D (May 1998) Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation., The American Journal of Clinical Nutrition, 67 (5), 927-33 Abstract
  • Robien K, Ulrich CM, Bigler J, Yasui Y, Gooley T, Bruemmer B, Potter JD, Radich JP (Nov 2004) Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia., Clinical Cancer Research : an Official Journal of the American Association for Cancer Research., 10 (22), 7592-8 Abstract
  • Slattery JT, Clift RA, Buckner CD, Radich J, Storer B, Bensinger WI, Soll E, Anasetti C, Bowden R, Bryant E, Chauncey T, Deeg HJ, Doney KC, Flowers M, Gooley T, Hansen JA, Martin PJ, McDonald GB, Nash R, Petersdorf EW, Sanders JE, Schoch G, Stewart P, Storb R, Appelbaum FR, Et Al. (Apr 1997) Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation., Blood, 89 (8), 3055-60 Abstract
  • Pagel JM, Appelbaum FR, Eary JF, Rajendran J, Fisher DR, Gooley T, Ruffner K, Nemecek E, Sickle E, Durack L, Carreras J, Horowitz MM, Press OW, Gopal AK, Martin PJ, Bernstein ID, Matthews DC (2006) 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission, Blood, 107, 2184-2191
  • Balduzzi A, Gooley T, Anasetti C, Sanders JE, Martin PJ, Petersdorf EW, Appelbaum FR, Buckner CD, Matthews D, Storb R, Et Al. (Oct 1995) Unrelated donor marrow transplantation in children., Blood, 86 (8), 3247-56 Abstract
  • Kansu E, Gooley T, Flowers ME, Anasetti C, Deeg HJ, Nash RA, Sanders JE, Witherspoon RP, Appelbaum FR, Storb R, Martin PJ (Dec 2001) Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial., Blood, 98 (13), 3868-70 Abstract
  • Demirer T, Gooley T, Buckner CD, Petersen FB, Lilleby K, Rowley S, Sanders J, Storb R, Appelbaum FR, Bensinger WI (Jun 1995) Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation., Bone Marrow Transplantation, 15 (6), 907-13 Abstract
  • Holmberg LA, Oparin DV, Gooley T, Lilleby K, Bensinger W, Reddish MA, MacLean GD, Longenecker BM, Sandmaier BM (Jun 2000) Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine., Bone Marrow Transplantation, 25 (12), 1233-41 Abstract
  • Lilleby K, Garcia P, Gooley T, McDonnell P, Taber R, Holmberg L, Maloney DG, Press OW, Bensinger W (2006) A prospective, randomized study of cryotherapy during administration of high-dise melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autolog, Bone Marrow Transplantation, 37, 1031-1035
  • Nash RA, Pineiro LA, Storb R, Deeg HJ, Fitzsimmons WE, Furlong T, Hansen JA, Gooley T, Maher RM, Martin P, McSweeney PA, Sullivan KM, Anasetti C, Fay JW (Nov 1996) FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors., Blood, 88 (9), 3634-41 Abstract
  • Storek J, Gooley T, Siadak M, Bensinger WI, Maloney DG, Chauncey TR, Flowers M, Sullivan KM, Witherspoon RP, Rowley SD, Hansen JA, Storb R, Appelbaum FR (Dec 1997) Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease., Blood, 90 (12), 4705-9 Abstract
  • Rowley SD, Bensinger WI, Gooley TA, Buckner CD (May 1994) Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation., Blood, 83 (9), 2731-6 Abstract
  • Storek J, Gooley T, Witherspoon RP, Sullivan KM, Storb R (Feb 1997) Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts., American Journal of Hematology, 54 (2), 131-8 Abstract
  • Schiffman KS, Bensinger WI, Appelbaum FR, Rowley S, Lilleby K, Clift RA, Weaver CH, Demirer T, Sanders JE, Petersdorf S, Gooley T, Weiden P, Zuckerman N, Montgomery P, Maziarz R, Klarnet JP, Rivkin S, Trueblood K, Storb R, Holmberg L, Buckner CD (Jun 1996) Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease., Bone Marrow Transplantation, 17 (6), 943-50 Abstract
  • Storb R, Martin PJ, Zaucha JM, Bensinger WI, Flowers MED, Georges G, Gooley T, Chauncey TR, Storek J, Torok-Storb B (2002) Association of CD34 cell number with chronic graft-versus-host disease in adults (letter to the editor - response), Blood, 99 (10), 3875-3877
  • Anderson JE, Appelbaum FR, Schoch G, Gooley T, Anasetti C, Bensinger WI, Bryant E, Buckner CD, Chauncey TR, Clift RA, Doney K, Flowers M, Hansen JA, Martin PJ, Matthews DC, Sanders JE, Shulman H, Sullivan KM, Witherspoon RP, Storb R (Jan 1996) Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors., Blood, 87 (1), 51-8 Abstract
  • Press OW, Eary JF, Appelbaum FR, Martin PJ, Nelp WB, Glenn S, Fisher DR, Porter B, Matthews DC, Gooley T, Et Al. (Aug 1995) Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas., Lancet, 346 (8971), 336-40 Abstract
  • McSweeney PA, Nash RA, Sullivan KM, Storek J, Crofford LJ, Dansey R, Mayes MD, McDonagh KT, Nelson JL, Gooley TA, Holmberg LA, Chen CS, Wener MH, Ryan K, Sunderhaus J, Russell K, Rambharose J, Storb R, Furst DE (Sep 2002) High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes., Blood, 100 (5), 1602-10 Abstract
  • Schuening F, Longo WL, Atkinson ME, Zaboikin M, Kiem HP, Sanders J, Scott CR, Storb R, Miller AD, Reynolds T, Bensinger W, Rowley S, Gooley T, Darovsky B, Appelbaum F (Nov 1997) Retrovirus-mediated transfer of the cDNA for human glucocerebrosidase into peripheral blood repopulating cells of patients with Gaucher's disease., Human Gene Therapy, 8 (17), 2143-60 Abstract
  • Feinstein LC, Sandmaier BM, Maloney DG, Maris MB, Gooley TA, Chauncey TR, Hegenbart U, McSweeney PA, Stuart MJ, Forman SJ, Agura EA, Pulsipher MA, Blume KG, Niederwieser DW, Storb RF (Apr 2003) Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 9 (4), 266-72 Abstract
  • Zivin JR, Gooley T, Zager RA, Ryan MJ (Apr 2001) Hypocalcemia: a pervasive metabolic abnormality in the critically ill., American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation., 37 (4), 689-98 Abstract
  • Torok-Storb B, Boeckh M, Hoy C, Leisenring W, Myerson D, Gooley T (Sep 1997) Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation., Blood, 90 (5), 2097-102 Abstract
  • Goerner M, Gooley T, Flowers ME, Sullivan KM, Kiem HP, Sanders JE, Martin PJ, Storb R (2002) Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 8 (1), 47-56 Abstract
  • Nichols WG, Corey L, Gooley T, Davis C, Boeckh M (Feb 2002) High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effect, The Journal of Infectious Diseases, 185 (3), 273-82 Abstract
  • Nash RA, Bowen JD, McSweeney PA, Pavletic SZ, Maravilla KR, Park MS, Storek J, Sullivan KM, Al-Omaishi J, Corboy JR, DiPersio J, Georges GE, Gooley TA, Holmberg LA, LeMaistre CF, Ryan K, Openshaw H, Sunderhaus J, Storb R, Zunt J, Kraft GH (Oct 2003) High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis., Blood, 102 (7), 2364-72 Abstract
  • Bensinger WI, Clift R, Martin P, Appelbaum FR, Demirer T, Gooley T, Lilleby K, Rowley S, Sanders J, Storb R, Buckner CD (Oct 1996) Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation., Blood, 88 (7), 2794-800 Abstract
  • Petersdorf EW, Hansen JA, Martin PJ, Woolfrey A, Malkki M, Gooley T, Storer B, Mickelson E, Smith A, Anasetti C (Dec 2001) Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation., The New England Journal of Medicine, 345 (25), 1794-800 Abstract
  • Weissinger F, Sandmaier BM, Maloney DG, Bensinger WI, Gooley T, Storb R (Dec 2001) Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings., Blood, 98 (13), 3584-8 Abstract
  • Giaccone L, McCune JS, Maris MB, Gooley TA, Sandmaier BM, Slattery JT, Cole S, Nash RA, Storb RF, Georges GE (2005) Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation, Blood, 106 (9), 4381-4388
  • Nemecek ER, Gooley TA, Woolfrey AE, Carpenter PA, Matthews DC, Sanders JE (Nov 2004) Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia., Bone Marrow Transplantation, 34 (9), 799-806 Abstract
  • Martin PJ, Rowley SD, Anasetti C, Chauncey TR, Gooley T, Petersdorf EW, van Burik JA, Flowers ME, Storb R, Appelbaum FR, Hansen JA (Oct 1999) A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients., Blood, 94 (7), 2192-9 Abstract
  • Carpenter PA, Appelbaum FR, Corey L, Deeg HJ, Doney K, Gooley T, Krueger J, Martin P, Pavlovic S, Sanders J, Slattery J, Levitt D, Storb R, Woolfrey A, Anasetti C (Apr 2002) A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease., Blood, 99 (8), 2712-9 Abstract
  • Kerbauy FR, Storb R, Hegenbart U, Gooley T, Shizuru J, Al-Ali HK, Radich JP, Maloney DG, Agura E, Bruno B, Epner EM, Chauncey TR, Blume KG, Niederwieser D, Sandmaier BM (Jun 2005) Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML., Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 19 (6), 990-7 Abstract
  • Petersdorf EW, Gooley T, Malkki M, Anasetti C, Martin P, Woolfrey A, Smith A, Mickelson E, Hansen JA (Mar 2001) The biological significance of HLA-DP gene variation in haematopoietic cell transplantation., British Journal of Haematology, 112 (4), 988-94 Abstract
  • Lin MT, Tseng LH, Frangoul H, Gooley T, Pei J, Barsoukov A, Akatsuka Y, Hansen JA (Jun 2000) Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation., Blood, 95 (12), 3832-9 Abstract
  • Bowden RA, Cays M, Gooley T, Mamelok RD, van Burik JA (May 1996) Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant., The Journal of Infectious Diseases, 173 (5), 1208-15 Abstract
  • Gibbs JP, Gooley T, Corneau B, Murray G, Stewart P, Appelbaum FR, Slattery JT (Jun 1999) The impact of obesity and disease on busulfan oral clearance in adults., Blood, 93 (12), 4436-40 Abstract
  • Martin PJ, Pei J, Gooley T, Anasetti C, Appelbaum FR, Deeg J, Hansen JA, Nash RA, Petersdorf EW, Storb R, Ghetie V, Schindler J, Vitetta ES (Aug 2004) Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 10 (8), 552-60 Abstract
  • McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG, Chauncey TR, Gooley TA, Hegenbart U, Nash RA, Radich J, Wagner JL, Minor S, Appelbaum FR, Bensinger WI, Bryant E, Flowers ME, Georges GE, Grumet FC, Kiem HP, Torok-Storb B, Yu C, Blume KG, Storb RF (Jun 2001) Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects., Blood, 97 (11), 3390-400 Abstract
  • Randolph SS, Gooley TA, Warren EH, Appelbaum FR, Riddell SR (Jan 2004) Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants., Blood, 103 (1), 347-52 Abstract
  • Georges GE, Storb R, Thompson JD, Yu C, Gooley T, Bruno B, Nash RA (May 2000) Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation., Blood, 95 (10), 3262-9 Abstract
  • Brunvand MW, Bensinger WI, Soll E, Weaver CH, Rowley SD, Appelbaum FR, Lilleby K, Clift RA, Gooley TA, Press OW, Fefer A, Storb R, Sanders JE, Martin PL, Chauncey T, Maziarz RT, Zuckerman N, Montgomery P, Dorn R, Weiden PL, Demirer T, Holmberg LA, Schiffman K, McSweeney PA, Buckner CD, Et Al. (Jul 1996) High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells., Bone Marrow Transplantation, 18 (1), 131-41 Abstract
  • Hawkins DS, Felgenhauer J, Park J, Kreissman S, Thomson B, Douglas J, Rowley SD, Gooley T, Sanders JE, Pendergrass TW (Sep 2002) Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas., Cancer, 95 (6), 1354-65 Abstract
  • Morton AJ, Gooley T, Hansen JA, Appelbaum FR, Bruemmer B, Bjerke JW, Clift R, Martin PJ, Petersdorf EW, Sanders JE, Storb R, Sullivan KM, Woolfrey A, Anasetti C (Jul 1998) Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase., Blood, 92 (2), 394-401 Abstract
  • Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ, Hansen JA (Dec 2003) Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation., The New England Journal of Medicine, 349 (23), 2201-10 Abstract
  • Sanders JE, Im HJ, Hoffmeister PA, Gooley TA, Woolfrey AE, Carpenter PA, Andrews RG, Bryant EM, Appelbaum FR (May 2005) Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia., Blood, 105 (9), 3749-56 Abstract
  • Radich JP, Gooley T, Bryant E, Chauncey T, Clift R, Beppu L, Edmands S, Flowers ME, Kerkof K, Nelson R, Appelbaum FR (Sep 2001) The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation., Blood, 98 (6), 1701-7 Abstract
  • Gooley TA, Rajvanshi P, Schoch HG, McDonald GB (Feb 2005) Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation., Hepatology (baltimore, Md.), 41 (2), 345-52 Abstract
  • Maciej Zaucha J, Mielcarek M, Takatu A, Little MT, Gooley T, Baker J, Maloney DG, Sandmaier BM, Maris M, Chauncey T, Storb R, Torok-Storb B (Dec 2002) Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation., British Journal of Haematology, 119 (3), 740-50 Abstract
  • Sandmaier BM, Fukuda T, Gooley T, Yu C, Santos EB, Storb R (Feb 2003) Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model., Experimental Hematology, 31 (2), 168-75 Abstract
  • Shulman HM, Gooley T, Dudley MD, Kofler T, Feldman R, Dwyer D, McDonald GB (Apr 1995) Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients., Transplantation, 59 (7), 1015-22 Abstract
  • Baron F, Baker JE, Storb R, Gooley TA, Sandmaier BM, Maris MB, Maloney DG, Heimfeld S, Oparin D, Zellmer E, Radich JP, Grumet FC, Blume KG, Chauncey TR, Little MT (Oct 2004) Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning., Blood, 104 (8), 2254-62 Abstract
  • Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, Doney K, Storb R, Sullivan K, Witherspoon R, Appelbaum FR (Apr 1996) Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation., Blood, 87 (7), 3045-52 Abstract
  • Gooley T, Storer B, Press OW (2001) Statistical designs for clinical trials of radioimmunotherapy (letter to the editor), Blood, 98 (4), 1275-1276
  • Georges GE, Storb R, Maciej Zaucha J, Taranova AG, Gooley T, Nash RA (Jun 2003) IL-2 does not enhance the conversion to complete donor chimerism following nonmyeloablative hematopoietic cell transplantation in dogs., Bone Marrow Transplantation, 31 (11), 1027-31 Abstract
  • Baehr PH, Levine DS, Bouvier ME, Hockenbery DM, Gooley TA, Stern JG, Martin PJ, McDonald GB (Dec 1995) Oral beclomethasone dipropionate for treatment of human intestinal graft-versus-host disease., Transplantation, 60 (11), 1231-8 Abstract
  • Chien JW, Martin PJ, Gooley TA, Flowers ME, Heckbert SR, Nichols WG, Clark JG (Jul 2003) Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation., American Journal of Respiratory and Critical Care Medicine, 168 (2), 208-14 Abstract
  • Schiffman K, Buckner CD, Maziarz R, Maloney DG, Appelbaum FR, Press O, Gooley T, Holmberg L, Lilleby K, Clift R, Zuckerman N, Klarnet J, Weaver C, Chauncey T, Bensinger WI (Nov 1997) High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 3 (5), 261-6 Abstract
  • Deeg HJ, Beckham C, Loken MR, Bryant E, Lesnikova M, Shulman HM, Gooley T (Apr 2000) Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome., Leukemia & Lymphoma, 37 (3-4), 405-14 Abstract
  • Mielcarek M, Gooley T, Martin PJ, Chauncey TR, Young BA, Storb R, Torok-Storb B (Mar 2005) Effects of race on survival after stem cell transplantation., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 11 (3), 231-9 Abstract
  • Radich J, Gehly G, Lee A, Avery R, Bryant E, Edmands S, Gooley T, Kessler P, Kirk J, Ladne P, Thomas ED, Appelbaum FR (Apr 1997) Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation., Blood, 89 (7), 2602-9 Abstract
  • Huss R, Deeg HJ, Gooley T, Bryant E, Leisenring W, Clift R, Buckner CD, Martin P, Storb R, Appelbaum FR (Oct 1996) Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia., Bone Marrow Transplantation, 18 (4), 767-76 Abstract
  • Gopal AK, Rajendran JG, Petersdorf SH, Maloney DG, Eary JF, Wood BL, Gooley TA, Bush SA, Durack LD, Martin PJ, Matthews DC, Appelbaum FR, Bernstein ID, Press OW (May 2002) High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma., Blood, 99 (9), 3158-62 Abstract
  • Wells DA, Sale GE, Shulman HM, Myerson D, Bryant EM, Gooley T, Loken MR (Jul 1998) Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation., American Journal of Clinical Pathology, 110 (1), 84-94 Abstract
  • Holmberg L, Kikuchi K, Gooley TA, Adams KM, Hockenbery DM, Flowers MED, Schoch HG, Bensinger W, McDonald GB (2006) Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: Incidence, risk factors, and outcome, Biology of Blood and Marrow Transplantation, 12, 226-234
  • Shulman HM, Wells D, Gooley T, Myerson D, Bryant E, Loken MR (Oct 1999) The biologic significance of rare peripheral blasts after hematopoietic cell transplantation is predicted by multidimensional flow cytometry., American Journal of Clinical Pathology, 112 (4), 513-23 Abstract
  • Anderson JE, Anasetti C, Appelbaum FR, Schoch G, Gooley TA, Hansen JA, Buckner CD, Sanders JE, Sullivan KM, Storb R (Apr 1996) Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia., British Journal of Haematology, 93 (1), 59-67 Abstract
  • Nash RA, Etzioni R, Storb R, Furlong T, Gooley T, Anasetti C, Appelbaum FR, Doney K, Martin P, Slattery J, Et Al. (Jun 1995) Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched sibli, Blood, 85 (12), 3746-53 Abstract
  • Bensinger WI, Longin K, Appelbaum F, Rowley S, Weaver C, Lilleby K, Gooley T, Lynch M, Higano T, Klarnet J, Et Al. (Aug 1994) Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after tran, British Journal of Haematology, 87 (4), 825-31 Abstract
  • Dell'Agnola C, Wang Z, Storb R, Tapscott SJ, Kuhr CS, Hauschka SD, Lee RS, Sale GE, Zellmer E, Gisburne S, Bogan J, Kornegay JN, Cooper BJ, Gooley TA, Little MT (Dec 2004) Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs., Blood, 104 (13), 4311-8 Abstract
  • Radich J, Ladne P, Gooley T (Nov 1995) Polymerase chain reaction-based detection of minimal residual disease in acute lymphoblastic leukemia predicts relapse after allogeneic BMT., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 1 (1), 24-31 Abstract
  • Anderson JE, Appelbaum FR, Schoch G, Gooley T, Anasetti C, Bensinger WI, Bryant E, Buckner CD, Chauncey T, Clift RA, Et Al. (Jan 1996) Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 14 (1), 220-6 Abstract
  • Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon J-D, Bornhauser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E (2006) KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy, Biology of Blood and Marrow Transplantation, 12 (8), 828-836
  • Hawkins D, Barnett T, Bensinger W, Gooley T, Sanders J (May 2000) Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumors., Medical and Pediatric Oncology, 34 (5), 328-37 Abstract
  • Boeckh M, Gooley TA, Myerson D, Cunningham T, Schoch G, Bowden RA (Nov 1996) Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study., Blood, 88 (10), 4063-71 Abstract
  • Tseng LH, Lin MT, Hansen JA, Gooley T, Pei J, Smith AG, Martin EG, Petersdorf EW, Martin PJ (Oct 1999) Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation., Blood, 94 (8), 2911-4 Abstract
  • Ko CW, Gooley T, Schoch HG, Myerson D, Hackman RC, Shulman HM, Sale GE, Lee SP, McDonald GB (Dec 1997) Acute pancreatitis in marrow transplant patients: prevalence at autopsy and risk factor analysis., Bone Marrow Transplantation, 20 (12), 1081-6 Abstract
  • Rowley SD, Yu J, Gooley T, Heimfeld S, Holmberg L, Maloney D, Bensinger WI (Oct 2001) Trafficking of CD34+ cells into the peripheral circulation during collection of peripheral blood stem cells by apheresis., Bone Marrow Transplantation, 28 (7), 649-56 Abstract
  • Anderson JE, Gooley TA, Schoch G, Anasetti C, Bensinger WI, Clift RA, Hansen JA, Sanders JE, Storb R, Appelbaum FR (Apr 1997) Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy., Blood, 89 (7), 2578-85 Abstract
  • Zaucha JM, Gooley T, Bensinger WI, Heimfeld S, Chauncey TR, Zaucha R, Martin PJ, Flowers ME, Storek J, Georges G, Storb R, Torok-Storb B (Dec 2001) CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-ho, Blood, 98 (12), 3221-7 Abstract
  • Fukuda T, Kerbauy FR, Gooley T, Santos EB, Storb R, Sandmaier BM (2006) Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model, Transplantation, 82 (3), 332-339
  • Sullivan KM, Anasetti C, Horowitz M, Rowlings PA, Petersdorf EW, Martin PJ, Clift RA, Walters MC, Gooley T, Sierra J, Anderson JE, Bjerke J, Siadak M, Flowers ME, Nash RA, Sanders JE, Appelbaum FR, Storb R, Hansen JA (Jun 1998) Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marro, Annals of the New York Academy of Sciences, 850, 312-24 Abstract
  • Weaver CH, Petersen FB, Appelbaum FR, Bensinger WI, Press O, Martin P, Sandmaier B, Deeg HJ, Hansen JA, Brunvand M, Rowley S, Benyunes K, Chauncey T, Fefer A, Hackman R, Gooley T, Schiffman K, Storb R, Sullivan KM, Weiden P, Witherspoon R, Buckner CD (1994) High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma, Journal of Clinical Oncology, 12, 2559-2566
  • Zerr DM, Gooley TA, Yeung L, Huang ML, Carpenter P, Wade JC, Corey L, Anasetti C (Sep 2001) Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients., Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America., 33 (6), 763-71 Abstract
  • Radich JP, Gooley T, Bensinger W, Chauncey T, Clift R, Flowers M, Martin P, Slattery J, Sultan D, Appelbaum FR (Jul 2003) HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen., Blood, 102 (1), 31-5 Abstract
  • Kerbauy DM, Chyou F, Gooley T, Sorror ML, Scott B, Pagel JM, Myerson D, Appelbaum FR, Storb R, Deeg HJ (Sep 2005) Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 11 (9), 713-20 Abstract
  • Nichols WG, Corey L, Gooley T, Davis C, Boeckh M (Aug 2001) Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome., Blood, 98 (3), 573-8 Abstract
  • Lambert NC, Evans PC, Hashizumi TL, Maloney S, Gooley T, Furst DE, Nelson JL (Jun 2000) Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity., Journal of Immunology (baltimore, Md. : 1950), 164 (11), 5545-8 Abstract
  • Nichols WG, Price TH, Gooley T, Corey L, Boeckh M (May 2003) Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products., Blood, 101 (10), 4195-200 Abstract
  • Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, Smith A, Bean MA, Ober C, Bianchi DW (Feb 1998) Microchimerism and HLA-compatible relationships of pregnancy in scleroderma., Lancet, 351 (9102), 559-62 Abstract
  • Schuening FG, von Kalle C, Kiem HP, Appelbaum FR, Deeg HJ, Pepe M, Gooley T, Graham TC, Hackman RC, Storb R (Nov 1997) Effect of recombinant canine stem cell factor, a c-kit ligand, on hematopoietic recovery after DLA-identical littermate marrow transplants in dogs., Experimental Hematology, 25 (12), 1240-5 Abstract
  • Feinstein LC, Sandmaier BM, Hegenbart U, McSweeney PA, Maloney DG, Gooley TA, Maris MB, Chauncey TR, Bruno B, Appelbaum FR, Niederwieser DW, Storb RF (Jan 2003) Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission., British Journal of Haematology, 120 (2), 281-8 Abstract
  • Stirewalt DL, Guthrie KA, Beppu L, Bryant EM, Doney K, Gooley T, Appelbaum FR, Radich JP (Mar 2003) Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 9 (3), 206-12 Abstract
  • Tse W, Deeg HJ, Stirewalt D, Appelbaum FR, Radich J, Gooley T (2004) Increased AF1q gene expression in high-risk myelodysplastic syndrome, British Journal of Haematology, 128, 218-220
  • Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C, Et Al. (Oct 1995) Factors that influence collection and engraftment of autologous peripheral-blood stem cells., Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 13 (10), 2547-55 Abstract
  • McDonald GB, Bouvier M, Hockenbery DM, Stern JM, Gooley T, Farrand A, Murakami C, Levine DS (Jul 1998) Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial., Gastroenterology, 115 (1), 28-35 Abstract
  • Jurado M, Deeg H, Gooley T, Anasetti C, Chauncey T, Flowers M, Myerson D, Storb R, Appelbaum F (Feb 2001) Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia., British Journal of Haematology, 112 (2), 392-6 Abstract
  • Lin M-T, Storer B, Martin PJ, Tseng L-H, Gooley T, Chen P-J, Hansen JA, Associations between cytokine gene polymorphisms and graft-versus-disease after marrow transplantation from an HLA-identical sibling, , HLA 2004: Immunobiology of the Human MHC. Proceedings of the 13th International Histocompatibility Workshop and Conference, Seattle, IHWG Press, In Press (bookchapter)

Profile Details

Last Updated: 2/5/2007

COS Expertise ID #1260652
Reference this profile directly: http://myprofile.cos.com/gooleyab4